Summary: Nature reports on the growing field of psychedelics, citing the increase in clinical trials involving psychedelics, decriminalization efforts in the United States, establishment of psychedelic research centers at esteemed institutions, and MAPS-sponsored research in MDMA-assisted therapy for posttraumatic stress disorder (PTSD). “Psychedelic-assisted psychotherapy could provide needed options for debilitating mental-health disorders including PTSD, major depressive disorder, alcohol-use disorder, anorexia nervosa and more that kill thousands every year in the United States, and cost billions worldwide in lost productivity,” writes author Paul Tullis.
Originally appearing here.